The INFORM-1 study described as 4 cohorts but is actually broken up into "sub" cohorts (my wording) this chart illustrates a little bit better. They really were cautious in proceeding with the first group only getting 4 days of the combo at very low doses. Slide from today's ITMN presentation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.